NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

MacLean CH, Mojica WA, Morton SC, et al. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Mar. (Evidence Reports/Technology Assessments, No. 89.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis

Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis.

Show details

Acknowledgments

We thank Herbert D. Woolf, PhD, of BASF Corporation for providing us with unpublished data on omega-3 fatty acids. We thank Antonio LaCava, MD, PhD for providing translation of Italian studies, Takahiro Higashi, MD for providing translation of Japanese studies, Markus Rihl, MD for providing translation of German studies, and Anna Maria Björnsdotter, BA, for providing translation of Swedish studies.

Chapter 1 was written in collaboration with the Tufts-New England Medical Center Evidence-based Practice Center.

Views

  • PubReader
  • Print View
  • Cite this Page

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...